- Email: [email protected]
DHC adds the Olive Leaf series to its skincare line
FOCUS of laundry detergent powder and fabric softeners. Sales were also affected by the firm’s move to discontinue some products. HAPPI, Household & Personal Products Industry, Sep 2003, 40 (9), 150
Alliance Pharmaceutical Corp announces 2002-2003 results Alliance Pharmaceutical Corp (APC) reported a net loss of $20.3 M for year ended Jun 2003 (net loss of $34.2 M in the year ended Jun 2002). Alliance Pharmaceutical is developing a synthetic therapeutic oxygen carrier, Oxygent, (red blood cell substitute) based on its perfluorochemical and surfactant technologies. Alliance Pharmaceutical 2002-2003 results, 14 Oct 2003 (Alliance Pharmaceutical Corp, 3040, Science Park Road, San Diego, CA 92121, USA. Tel: +1 858 410 5200. Fax: +1 858 410 5201. Website: http://www.allp.com)
Godrej Consumer 2Q 2003-2004 net profit dips marginally Godrej Consumer Products Ltd recorded a decline of 1% in its net profit at Rup 139 M on sales revenue of Rup 1.215 bn for 2Q 2003-2004 as against a net profit of Rup 140 M on sales revenue of Rup 1.186 bn in 2Q 2002-2003. Sales of Godrej brands increased by 11% to Rup 1.154 bn. The market share of the company’s toilet soaps increased to 6.6% for 2Q 2003-2004 compared to a market share of 5.6% in 2Q 2002-2003. During 1H ended Sep 2003, Godrej recorded a profit-after-tax of Rup 277 M on revenues of Rup 2.394 bn with brand sales accounting for Rup 2.221 bn. The company plans to strengthen its presence in the personal care products segment. Godrej Consumer plans to commission the soap manufacturing facility being set up in Himachal Pradesh during 4Q 20032004. Business Line, 23 Oct 2003, 10 (293), 2
Henkel SPIC: 3Q 2003 net profit down Henkel SPIC India Ltd reported a decline in net profit at Rup 15.3 M on net sales (including excise duty) of Rup 978.7 M for 3Q ended Sep 2003 compared to a net profit of Rup 20.8 M on net sales (including excise duty) of Rup 916.5 M in 3Q ended Sep NOVEMBER 2003
ON
S U R FAC TA N T S
2002. During the nine months ended Sep 2003, the company posted a net profit of Rup 34.9 M on net sales (including excise duty) of Rup 2600.3 M (net profit of Rup 49.3 M on net sales including excise duty of Rup 2539.2 M in nine months ended Sep 2002). Henkel SPIC derived revenues of Rup 623.6 M from its detergents and cleansers business, and Rup 355.1 from its cosmetics business for 3Q 2003 as against revenues of Rup 577.4 M from detergents and cleansers, and Rup 339.1 from cosmetics in 3Q 2002. Business Line, 24 Oct 2003, 10 (294), 9
and cosmetics ingredients. Japan Chemical Week, 9 Oct 2003, 44 (2240), 2
Siltech adds capacity Silicone compounds and speciality surfactants maker Siltech has expanded capacity at its Toronto plant by around 7 M kg/y to over 10 M kg/y. The company is also concluding distribution deals with around 10 Asian-based companies to cover Indonesia, Malaysia, the Philippines, Singapore and Thailand. Siltech products are used in personal care, PU foam, inks and coatings, and textile applications. Chemical Week, 1 Oct 2003, 165 (35), 26
COMPANY NEWS Orion sells Noiro Orion, Finland, is involved in pharmaceuticals. It has sold its Noiro cosmetics and detergents business to CapMan, Finland, a private equity investor, for €100 M. The name Noiro will be retained. Noiro achieved an operating profit of €9.8 M in 2002, with sales of €135.3 M. European Chemical News, 6 Oct 2003, 79 (2071), 8
Clariant (Japan) augmenting base of speciality products business The speciality products sector of Clariant (Japan) KK is being strengthened following the restructuring of its parent company with the sale of the cellulose ether and electronics materials operations. The Japanese company will concentrate on strengthening its pigments and additives, textile/leather/paper (TLP) chemicals, dyes and performance chemicals sectors. From Spring 2003, a new managerial responsibility structure has been introduced. In 2002, Clariant (Japan) achieved sales of Yen 43 bn from its electronic materials operations and the divestment of this sector will have a significant impact on its business. There has been steady growth in sales of pigments and additives for non-impact printing applications and sales are firm for TLP and detergent
P&G looks at India for global innovation and knowledge needs The Procter & Gamble Co (P&G), USA, is looking at collaborations with both companies and individuals in India for its global innovations and knowledge needs. These collaborations will improve P&G’s global R&D facilities, provide advanced innovations, superior products and cost efficiency. P&G is targeting the areas of product formulation, colloid chemistry, speciality polymers, cleaning agents, enzymes, oral care products, packaging, absorbents, capillary fibre structures, flavours and fragrances, and clinical services. Express Pharma Pulse, 2 Oct 2003, 9 (45), 11
DHC adds the Olive Leaf Series to its skincare line DHC Corp continues its product expansion with the introduction of the Olive Leaf series, which includes Olive Soap and lotions. As its name suggests, the key ingredient of this series is olive leaf extract, which contains coenzyme Q10, a vitaminlike compound found naturally in the body. Coenzyme Q10 (also known as CoQ10) aids the skin in its formation of collagen and elastin for increased firmness and suppleness. Additional ingredients include virgin olive oil, the signature ingredient in DHC’s skincare line. Press release from: DHC USA Inc, 450, Townsend, San Francisco, CA 94107, USA. Website: http://www.dhccare.com (17 Oct 2003)
7
Alliance Pharmaceutical Corp announces 2002-2003 results Alliance Pharmaceutical Corp (APC) reported a net loss of $20.3 M for year ended Jun 2003 (net loss of $34.2 M in the year ended Jun 2002). Alliance Pharmaceutical is developing a synthetic therapeutic oxygen carrier, Oxygent, (red blood cell substitute) based on its perfluorochemical and surfactant technologies. Alliance Pharmaceutical 2002-2003 results, 14 Oct 2003 (Alliance Pharmaceutical Corp, 3040, Science Park Road, San Diego, CA 92121, USA. Tel: +1 858 410 5200. Fax: +1 858 410 5201. Website: http://www.allp.com)
Godrej Consumer 2Q 2003-2004 net profit dips marginally Godrej Consumer Products Ltd recorded a decline of 1% in its net profit at Rup 139 M on sales revenue of Rup 1.215 bn for 2Q 2003-2004 as against a net profit of Rup 140 M on sales revenue of Rup 1.186 bn in 2Q 2002-2003. Sales of Godrej brands increased by 11% to Rup 1.154 bn. The market share of the company’s toilet soaps increased to 6.6% for 2Q 2003-2004 compared to a market share of 5.6% in 2Q 2002-2003. During 1H ended Sep 2003, Godrej recorded a profit-after-tax of Rup 277 M on revenues of Rup 2.394 bn with brand sales accounting for Rup 2.221 bn. The company plans to strengthen its presence in the personal care products segment. Godrej Consumer plans to commission the soap manufacturing facility being set up in Himachal Pradesh during 4Q 20032004. Business Line, 23 Oct 2003, 10 (293), 2
Henkel SPIC: 3Q 2003 net profit down Henkel SPIC India Ltd reported a decline in net profit at Rup 15.3 M on net sales (including excise duty) of Rup 978.7 M for 3Q ended Sep 2003 compared to a net profit of Rup 20.8 M on net sales (including excise duty) of Rup 916.5 M in 3Q ended Sep NOVEMBER 2003
ON
S U R FAC TA N T S
2002. During the nine months ended Sep 2003, the company posted a net profit of Rup 34.9 M on net sales (including excise duty) of Rup 2600.3 M (net profit of Rup 49.3 M on net sales including excise duty of Rup 2539.2 M in nine months ended Sep 2002). Henkel SPIC derived revenues of Rup 623.6 M from its detergents and cleansers business, and Rup 355.1 from its cosmetics business for 3Q 2003 as against revenues of Rup 577.4 M from detergents and cleansers, and Rup 339.1 from cosmetics in 3Q 2002. Business Line, 24 Oct 2003, 10 (294), 9
and cosmetics ingredients. Japan Chemical Week, 9 Oct 2003, 44 (2240), 2
Siltech adds capacity Silicone compounds and speciality surfactants maker Siltech has expanded capacity at its Toronto plant by around 7 M kg/y to over 10 M kg/y. The company is also concluding distribution deals with around 10 Asian-based companies to cover Indonesia, Malaysia, the Philippines, Singapore and Thailand. Siltech products are used in personal care, PU foam, inks and coatings, and textile applications. Chemical Week, 1 Oct 2003, 165 (35), 26
COMPANY NEWS Orion sells Noiro Orion, Finland, is involved in pharmaceuticals. It has sold its Noiro cosmetics and detergents business to CapMan, Finland, a private equity investor, for €100 M. The name Noiro will be retained. Noiro achieved an operating profit of €9.8 M in 2002, with sales of €135.3 M. European Chemical News, 6 Oct 2003, 79 (2071), 8
Clariant (Japan) augmenting base of speciality products business The speciality products sector of Clariant (Japan) KK is being strengthened following the restructuring of its parent company with the sale of the cellulose ether and electronics materials operations. The Japanese company will concentrate on strengthening its pigments and additives, textile/leather/paper (TLP) chemicals, dyes and performance chemicals sectors. From Spring 2003, a new managerial responsibility structure has been introduced. In 2002, Clariant (Japan) achieved sales of Yen 43 bn from its electronic materials operations and the divestment of this sector will have a significant impact on its business. There has been steady growth in sales of pigments and additives for non-impact printing applications and sales are firm for TLP and detergent
P&G looks at India for global innovation and knowledge needs The Procter & Gamble Co (P&G), USA, is looking at collaborations with both companies and individuals in India for its global innovations and knowledge needs. These collaborations will improve P&G’s global R&D facilities, provide advanced innovations, superior products and cost efficiency. P&G is targeting the areas of product formulation, colloid chemistry, speciality polymers, cleaning agents, enzymes, oral care products, packaging, absorbents, capillary fibre structures, flavours and fragrances, and clinical services. Express Pharma Pulse, 2 Oct 2003, 9 (45), 11
DHC adds the Olive Leaf Series to its skincare line DHC Corp continues its product expansion with the introduction of the Olive Leaf series, which includes Olive Soap and lotions. As its name suggests, the key ingredient of this series is olive leaf extract, which contains coenzyme Q10, a vitaminlike compound found naturally in the body. Coenzyme Q10 (also known as CoQ10) aids the skin in its formation of collagen and elastin for increased firmness and suppleness. Additional ingredients include virgin olive oil, the signature ingredient in DHC’s skincare line. Press release from: DHC USA Inc, 450, Townsend, San Francisco, CA 94107, USA. Website: http://www.dhccare.com (17 Oct 2003)
7